APA (7th ed.) Citation

Ni, X., Feng, X., Wang, Z., Zhang, Y., Little, P. J., Cao, Y., . . . Weng, J. (2024). Empagliflozin and liraglutide ameliorate HFpEF in mice via augmenting the Erbb4 signaling pathway. Acta Pharmacologica Sinica, 45(8), 1604-1617. https://doi.org/10.1038/s41401-024-01265-0

Chicago Style (17th ed.) Citation

Ni, Xia-yun, Xiao-jun Feng, Zhi-hua Wang, Yang Zhang, Peter J. Little, Yang Cao, Suo-wen Xu, Li-qin Tang, and Jian-ping Weng. "Empagliflozin and Liraglutide Ameliorate HFpEF in Mice via Augmenting the Erbb4 Signaling Pathway." Acta Pharmacologica Sinica 45, no. 8 (2024): 1604-1617. https://doi.org/10.1038/s41401-024-01265-0.

MLA (9th ed.) Citation

Ni, Xia-yun, et al. "Empagliflozin and Liraglutide Ameliorate HFpEF in Mice via Augmenting the Erbb4 Signaling Pathway." Acta Pharmacologica Sinica, vol. 45, no. 8, 2024, pp. 1604-1617, https://doi.org/10.1038/s41401-024-01265-0.